Kavin Sugumar, MD @KavinSugumar X Profile

Kavin Sugumar, MD

@KavinSugumar

Followers

567

Following

877

Media

37

Statuses

181

PGY5 @Tulane_Surgery | Alumni: research fellow @winterlab8 & #GenSurg from SethGS & KEM, Mumbai

https://t.co/2qQZK4hzqX

New Orleans, LA

Joined January 2014

Don't wanna be here? Send us removal request.

Jash Datta, MD

@DrJashDatta

6 months

We couldn’t be happier to have matched these two outstanding surgeons @KavinSugumar @Tulane_Surgery & @edmondboxmd @USFsurgery to our #CGSO #SurgOnc @SocSurgOnc fellowship @SylvesterCancer @UMJMHSurgery

Nipun Merchant

@NbmerchantMD

6 months

Thrilled to welcome Edmond Box, MD @edmondboxmd, Kavin Sugumar, MD @KavinSugumar as our newest CGSO fellows at @umiamimedicine / @SylvesterCancer.

4

8

40

Kavin Sugumar, MD

@KavinSugumar

6 months

Absolutely thrilled to have matched at @UMiamiHealth @SylvesterCancer ☺️ Huge thanks to my mentors, family and friends for their unconditional support. Can’t wait to begin my training at Miami 🏖️ @SocSurgOnc #CGSOMatch

Nipun Merchant

@NbmerchantMD

6 months

Thrilled to welcome Edmond Box, MD @edmondboxmd, Kavin Sugumar, MD @KavinSugumar as our newest CGSO fellows at @umiamimedicine / @SylvesterCancer.

7

6

64

Kavin Sugumar, MD

@KavinSugumar

6 months

Check out our multi-center study on exceptional responders to immunotherapy in #PDAC. 58% were MSI-stable. @Oncotarget @JordanMWinterMD @winterlab8 @JJHUE @anup_kasi @UHSurgOncology https://t.co/4spCZ8QWWz

oncotarget.com

https://doi.org/10.18632/oncotarget.28739 Kavin Sugumar, Andrew Alabd, Andre Alabd, Jonathan J. Hue, Josh Lyons, Sherri Fields, Zev Wainberg, Lei Zheng, Brianna Coogle, Anup Kasi, Nicholas Grewal,...

0

1

3

Kavin Sugumar, MD

@KavinSugumar

8 months

Check out our study on the incidence of progression of Bethesda II -> III/IV #thyroid nodules following #RFA (radio frequency ablation). @EmadKandil11 @Tulane_Surgery @WileyGlobal https://t.co/GHqtaRd1oU

onlinelibrary.wiley.com

This prospective study of 312 patients with benign thyroid nodules treated with radiofrequency ablation showed a 3.84% progression to Bethesda III cytology, all confirmed benign by molecular testin...

0

2

Lee M. Ocuin MD, FACS

@TheNotoriousHPB

11 months

Excellent work by @KavinSugumar. #HAI should be a consideration in patients with unresectable #ColorectalLiverMetastases IF expertise is available. EA2222 will answer the question. @michael_lidsky @MichaelDAngeli2 @skmaithel @jordanberlin5 @FlavioRochaMD @HalletJulie @eaonc

Annals of Surgical Oncology

@AnnSurgOncol

11 months

#AudioVisualAbstract : Outcomes of Hepatic Artery-Based Therapies and Systemic #MultiagentChemotherapy in Unresectable #ColorectalLiverMetastases : A Systematic Review and Meta-analysis @KavinSugumar @TheNotoriousHPB https://t.co/ub8UTA1sXz @jhatjhmi1 @SyedAAhmad5

0

2

11

Annals of Surgical Oncology

@AnnSurgOncol

11 months

#AudioVisualAbstract : Outcomes of Hepatic Artery-Based Therapies and Systemic #MultiagentChemotherapy in Unresectable #ColorectalLiverMetastases : A Systematic Review and Meta-analysis @KavinSugumar @TheNotoriousHPB https://t.co/ub8UTA1sXz @jhatjhmi1 @SyedAAhmad5

0

7

19

Kavin Sugumar, MD

@KavinSugumar

1 year

Humbled to receive the 2024 Rudolph Matas Clinical Research Award by @Tulane_Surgery at the annual graduation. Grateful to all my mentors and colleagues 😊

5

4

33

Kavin Sugumar, MD

@KavinSugumar

2 years

Check out our meta-analysis on the prognostic role of biliary spillage during index cholecystectomy in #GallBladderCancer from @Tulane_Surgery @JeffDemond @DrAdarshVijay @DavidPointerMD @JSurgRes @AsianAcadSurg https://t.co/9gJfW4Ki5g

1

5

19

Lee M. Ocuin MD, FACS

@TheNotoriousHPB

2 years

Check out our author reflections on hepatic artery-based therapies for unresectable colorectal liver metastases. @KavinSugumar @AnnSurgOncol @SocSurgOnc @michael_lidsky @ryanwday @DrJashDatta @DrMikeCavnar @BasGrootKoerkam @FlavioRochaMD @SyedAAhmad5 https://t.co/nuobrUVepH

link.springer.com

Annals of Surgical Oncology -

0

9

42

Kavin Sugumar, MD

@KavinSugumar

2 years

Thank you for the shoutout 😊@KristenLimbach

Kristen Limbach

@KristenLimbach

2 years

Super 🌟alert! Congratulations to @KavinSugumar for a fantastic meta-analysis looking at HAIP therapy in unresectable metastatic #colorectalcancer. Way to represent @Tulane_Surgery #tulanesurgery

0

1

7

Kavin Sugumar, MD

@KavinSugumar

2 years

Check out our #metaanalysis looking at risk factors of developing NAFLD following #pancreatectomy. ♀️ gender, PDAC, adjuvant CT were significantly associated. #NAFLD @JordanMWinterMD @TheNotoriousHPB @jj_hue @AmmoriJohn @JournalofGISurg @SSATNews https://t.co/Ii4ROF0Nee

0

5

25

STITCHES - the Best Papers in General Surgery

@stitchestoday

2 years

Survival Benefits of Hepatic Artery Therapies in Colorectal Liver Metastases by Sugumar K, Stitzel H (...) Ocuin LM et 12 al. in Ann Surg Oncol https://t.co/g0GQmuuXyS

link.springer.com

Annals of Surgical Oncology - Treatment of unresectable colorectal liver metastases (UCRLM) includes locoregional and systemic therapy. A comprehensive analysis capturing long-term outcomes of...

0

6

15

Kavin Sugumar, MD

@KavinSugumar

2 years

Grateful for the opportunity to present our work from @Tulane_Surgery #UniversityHospitalsSurgery and #MayoClinicArizonaSurgery at #SSO2024 Thank you Dr. Ralph Corsetti, @TheNotoriousHPB and @ZhiVenFongMD for your mentorship 😊

4

5

27

Alpha Omega Alpha

@AOA_society

2 years

Congratulations! Welcome! We're pleased to have you both as new members. @itikagarg @KavinSugumar @TulaneMedicine

Itika Garg, MD

@itikagarg

2 years

Extremely grateful and honored to be inducted into the Alpha Omega Alpha Honor Medical Society @AOA_society @TulaneMedicine together 🌟🙏🤗 @KavinSugumar

2

11

Kavin Sugumar, MD

@KavinSugumar

2 years

Thank you @ZhiVenFongMD for all the mentorship and the opportunity to present #SSO2024 @SocSurgOnc

Zhi Ven Fong, MD MPH DrPH

@ZhiVenFongMD

2 years

Rising super⭐️ @KavinSugumar closing out #SSO2024 with an oral presentation on the correlation of path complete response w survival in rectal cancer! Path response does not correlate with survival in rectal ca - need to resist easy temptation to use as surrogate trial endpoint.

0

2

19

Itika Garg, MD

@itikagarg

2 years

Extremely grateful and honored to be inducted into the Alpha Omega Alpha Honor Medical Society @AOA_society @TulaneMedicine together 🌟🙏🤗 @KavinSugumar

7

5

70

Kristen Limbach

@KristenLimbach

2 years

Congratulations to @KavinSugumar for a phenomenal podium presentation regarding PCR as an end point in CRC trials at #sso2024! Maybe not such a great surrogate for OS. Great work!! @Tulane_Surgery

0

3

16

Lee M. Ocuin MD, FACS

@TheNotoriousHPB

2 years

Check out this systematic review and meta-analysis of arterial-based and systemic therapies, including #HAI, for unresectable colorectal liver metastases by @KavinSugumar. @JEvaSelfridge @MadisonConces @LumishMelissa @AmmoriJohn @hstitzel @VictoriaSWu_ https://t.co/0NfHuuL25v

link.springer.com

Annals of Surgical Oncology - Treatment of unresectable colorectal liver metastases (UCRLM) includes locoregional and systemic therapy. A comprehensive analysis capturing long-term outcomes of...

3

11

34

Kavin Sugumar, MD

@KavinSugumar

2 years

Thank you @TheNotoriousHPB for the mentorship and opportunity to present @SocSurgOnc #ACT2024

Lee M. Ocuin MD, FACS

@TheNotoriousHPB

2 years

@KavinSugumar presenting our comprehensive meta-analysis of systemic therapy and arterial-based therapy in patients with unresectable colorectal liver metastases at #ACT2024. We need trials and look forward to opening EA2222/The Pump Trial! @michael_lidsky @eaonc @colontown

0

1

20

Kavin Sugumar, MD

@KavinSugumar

2 years

Thank you @STaghaviMD 😊

Sharven Taghavi, MD, MPH, MS, FACS, FCCP

@STaghaviMD

2 years

Great talk by @KavinSugumar @AsianAcadSurg meeting representing @TulaneMedicine @Tulane_Surgery #SAAS2023

0

11